http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UY-27278-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| filingDate | 2002-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21919fca0cb6b6112cc5407051b50768 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_534683b566711b79535c693927381403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85804c667b68b86a3d7076a46de68387 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_243f122ea795eaf1203a973d761d4dd1 |
| publicationDate | 2002-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UY-27278-A1 |
| titleOfInvention | PHARMACEUTICAL DOSAGE FORM OF NELFINAVIR AMORFO MESYLATE |
| abstract | A solid unit oral pharmaceutical dosage form of amorphous nelfinavir mesylate comprising amorphous nelfinavir mesylate, and a synthetic, non-ionic polymer, blocking ethylene oxide and propylene oxide, soluble in water, pharmaceutically acceptable, having said said copolymer a melting point of at least 40sC. A hot melt granulation process is provided for the preparation of a dosage form. |
| priorityDate | 2002-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.